Literature DB >> 34363011

Late excess mortality in essential thrombocythemia: a population-based study in the Netherlands, 2001-2018.

Tom S M Posthuma1, Otto Visser2, Peter A W Te Boekhorst3, Avinash G Dinmohamed4,5,6,7.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34363011     DOI： 10.1038/s41375-021-01372-5

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  17 in total

1.  Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).

Authors:  Tiziano Barbui; Guido Finazzi; Alessandra Carobbio; Juergen Thiele; Francesco Passamonti; Elisa Rumi; Marco Ruggeri; Francesco Rodeghiero; Maria Luigia Randi; Irene Bertozzi; Heinz Gisslinger; Veronika Buxhofer-Ausch; Valerio De Stefano; Silvia Betti; Alessandro Rambaldi; Alessandro M Vannucchi; Ayalew Tefferi
Journal:  Blood       Date:  2012-10-01       Impact factor: 22.113

2.  Incidence of myeloproliferative neoplasms - trends by subgroup and age in a population-based study in Sweden.

Authors:  M Hultcrantz; A Ravn Landtblom; B Andréasson; J Samuelsson; P W Dickman; S Y Kristinsson; M Björkholm; T M-L Andersson
Journal:  J Intern Med       Date:  2020-01-11       Impact factor: 8.989

3.  Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study.

Authors:  Malin Hultcrantz; Sigurdur Yngvi Kristinsson; Therese M-L Andersson; Ola Landgren; Sandra Eloranta; Asa Rangert Derolf; Paul W Dickman; Magnus Björkholm
Journal:  J Clin Oncol       Date:  2012-07-16       Impact factor: 44.544

Review 4.  Essential Thrombocythemia.

Authors:  Ayalew Tefferi; Animesh Pardanani
Journal:  N Engl J Med       Date:  2019-11-28       Impact factor: 91.245

5.  Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

Authors:  R A Mesa; M N Silverstein; S J Jacobsen; P C Wollan; A Tefferi
Journal:  Am J Hematol       Date:  1999-05       Impact factor: 10.047

Review 6.  Essential thrombocythaemia: challenges and evidence-based management.

Authors:  Claire N Harrison
Journal:  Br J Haematol       Date:  2005-07       Impact factor: 6.998

Review 7.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

Review 8.  Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

Authors:  Tiziano Barbui; Giovanni Barosi; Alberto Grossi; Luigi Gugliotta; Lucio N Liberato; Monia Marchetti; Maria Gabriella Mazzucconi; Francesco Rodeghiero; Sante Tura
Journal:  Haematologica       Date:  2004-02       Impact factor: 9.941

9.  Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

Authors:  Marc Maynadié; Roberta De Angelis; Rafael Marcos-Gragera; Otto Visser; Claudia Allemani; Carmen Tereanu; Riccardo Capocaccia; Adriano Giacomin; Jean-Michel Lutz; Carmen Martos; Risto Sankila; Tom Børge Johannesen; Arianna Simonetti; Milena Sant
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

10.  Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors.

Authors:  Alexandra P Wolanskyj; Susan M Schwager; Rebecca F McClure; Dirk R Larson; Ayalew Tefferi
Journal:  Mayo Clin Proc       Date:  2006-02       Impact factor: 7.616
View more
  1 in total

1.  JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.

Authors:  Valérie Ugo; Damien Luque Paz; Léa Sureau; Caroline Buors; Jean-Christophe Ianotto; Françoise Boyer; Aline Tanguy-Schmidt; Lydia Roy; Emilie Cayssials; Laura Cailly; Jean-Claude Chomel; Aurélie Chauveau; Corentin Orvain; Olivier Mansier; Dana Ranta; Margot Robles; Emmanuel Gyan; Olivier Hérault; Stanislas Nimubona; Tony Marchand; Eric Lippert; Jérémie Riou
Journal:  Blood Cancer J       Date:  2022-04-08       Impact factor: 11.037
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.